Navigation Links
Vanda Pharmaceuticals Reports Third Quarter 2008 Results
Date:10/30/2008

7,017

Accretion of discount on investments (212,664) (1,315,609)

Changes in assets and liabilities:

Prepaid expenses and other

current assets (1,160,103) (1,414,371)

Accounts payable (2,089,044) 660,697

Accrued expenses (6,708,552) 5,544,227

Deferred grant revenue - (140,599)

Other liabilities 142,732 13,258

Net cash used in operating

activities (40,505,574) (35,019,750)

Cash flows from investing activities:

Purchases of property and equipment (943,659) (249,728)

Proceeds from sales of property and

equipment - 119,054

Purchases of marketable securities (11,491,577) (107,570,370)

Proceeds from sales of marketable

securities 10,373,251 -

Maturities of marketable securities 42,060,000 60,395,000

Net cash provided by (used in)

investing activities 39,998,015 (47,306,044)

Cash flows from financing activities:

Proceeds from exercise of stock

options and warrants - 103,176

Proceeds from issuance of common

stock, net of issuance costs - 111,254,850

Net cash provided by financing

activities - 111,358,026

Effect of foreign currency translation 16,745 (6,654)

Net increase (decrease) in cash and

cash equivalents (490,814) 29,025,578

Cash and cash equivalents, beginning

of period 41,929,53
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
2. Vanda Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
3. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
4. Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008
5. Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights
6. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
7. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Diego, California (PRWEB) January 22, 2015 ... Promotional Offer to their comprehensive portfolio of Eppendorf ... allows customers to purchase a Centrifuge 5424/5424 R and ... Bundle of either Eppendorf Research plus or Eppendorf Reference ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited to ... on probiotics in San Diego, CA. , The Scripps ... health care professionals. This year’s pre-conference seminar was held on ... Dr. Leyer spoke about the emerging topics and science in ...
(Date:1/22/2015)... 22, 2015 Selexis SA, a serial ... Cell Banks (RCBs) used for drug discovery to commercial ... will include Next-Generation Sequencing (NGS) data packages. ... biologic manufacturing by ensuring the integrity of the gene, ...
(Date:1/22/2015)... , 22 de enero de 2015  El Dr. ... su llamada a nominaciones para 2015. Este prestigioso premio ... o tiene el potencial para hacer, contribuciones destacadas para ... aceptarán hasta el 15 de marzo de 2015 a ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4
... 1, 2008 Piedmont Heart Institute (PHI),expands its ... practice, Cardiology of Georgia, P.C. (COG), through a ... With eight,locations including Buckhead, Canton, Fayetteville and North ... the Piedmont Heart Institute and an,important addition to ...
... and System Data into the Cisco Open Platform for ... Agencies to Protect ... Assets, Employees, and Citizens, MORGANTOWN, W.Va., April ... technologies, today announced it,has partnered with Cisco on the newly ...
... Dr. Roger Kenneth,Hershline, PhD, MD, the CEO of ... public charity CureHIV.us, announces today,that he is reaching out ... Grand Challenges in Global Health initiative. The,monies would be ... and treatment,method, LiSAVIOR., This unique new drug is ...
Cached Biology Technology:Piedmont Heart Institute Welcomes Cardiology of Georgia 2Piedmont Heart Institute Welcomes Cardiology of Georgia 3Piedmont Heart Institute Welcomes Cardiology of Georgia 4Augusta Systems Technologies Integrated into Cisco's Newly Launched Safety and Security Platform 2Augusta Systems Technologies Integrated into Cisco's Newly Launched Safety and Security Platform 3Cure HIV Reaches Out to Foundation Community to Fund LiSAVIOR 2
(Date:1/22/2015)... , Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ... in general the State of Washington,s ... a new enrollment and central issuance system for driver,s licenses ... The project planning and development will start in January ...
(Date:1/22/2015)... 13, 2015 Technology Showcase, Hall E -   EyeLock ... today announced it will showcase its EyeLock ID technology integrated ... Department of Energy,s Oak Ridge National Laboratory (ORNL) ... EyeLock,s iris identity authentication technology is being used to validate ...
(Date:1/22/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD and NXTDW) ... on the recent success of the Wocket™ smart wallet at CES 2015 ... wallet was named as one of the "11 Hot Products at CES" ... Launched At CES So Far" by Newseveryday.com and "The top 10 gadgets ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3
... is banned can have benefits that extend beyond the ... to new evidence from Australia,s Great Barrier Reef reported ... , a Cell Press publication. Researchers have found that ... ), which can devastate coral reefs, occur less often ...
... a new imaging system that allows them to see ... work, which could help scientists understand how precancerous mutations ... to pinpoint the number and location of mutant cellscells ... the researchers worked with mouse pancreatic cells. "Understanding ...
... infected with a second strain of the virus, the ... third, recombinant strain of the virus. It is ... superinfection, frequently leads to a loss of immune control ... Partners AIDS Research Center at Massachusetts General Hospital (PARC/MGH) ...
Cached Biology News:Fishing ban guards coral reefs against predatory starfish outbreaks 2MIT researchers offer glimpse of rare mutant cells 2Viral recombination another way HIV fools the immune system 2
PTC-100 cycler with gold/silver block with Hot Bonnet heated lid, holds one 96-well V-plate or96x0.2ml tubes...
... The DTX Series Multimode Detectors provide ... variety of application and automation needs. ... absorbance measurements on the same instrument, ... standalone instruments or can be integrated ...
... Deparaffinization Solution is available in a ... easy-to-use reagent for dewaxing paraffin-embedded tissue ... situ hybridization, or other analytical methods. ... consists of dipping the slides in ...
... Mini thermal cycler is a compact instrument for ... ml tubes, 12 x 0.5 ml tubes, or ... uses a thumbwheel to adjust height and pressure ... Peltier heat pumps provide excellent thermal performance, and ...
Biology Products: